Anne Cruickshank
Overview
Explore the profile of Anne Cruickshank including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallacher P, Miller-Hodges E, Shah A, Farrah T, Halbesma N, Blackmur J, et al.
Kidney Int
. 2022 Mar;
102(1):149-159.
PMID: 35271932
The benefit and utility of high-sensitivity cardiac troponin (hs-cTn) in the diagnosis of myocardial infarction in patients with kidney impairment is unclear. Here, we describe implementation of hs-cTnI testing on...
2.
Lee K, Ferry A, Anand A, Strachan F, Chapman A, Kimenai D, et al.
J Am Coll Cardiol
. 2019 Oct;
74(16):2032-2043.
PMID: 31623760
Background: Major disparities between women and men in the diagnosis, management, and outcomes of acute coronary syndrome are well recognized. Objectives: The aim of this study was to evaluate the...
3.
Bularga A, Lee K, Stewart S, Ferry A, Chapman A, Marshall L, et al.
Circulation
. 2019 Sep;
140(19):1557-1568.
PMID: 31475856
Background: Guidelines acknowledge the emerging role of high-sensitivity cardiac troponin (hs-cTnl) for risk stratification and the early rule-out of myocardial infarction, but multiple thresholds have been described. We evaluate the...
4.
Shah A, Anand A, Strachan F, Ferry A, Lee K, Chapman A, et al.
Lancet
. 2018 Sep;
392(10151):919-928.
PMID: 30170853
Background: High-sensitivity cardiac troponin assays permit use of lower thresholds for the diagnosis of myocardial infarction, but whether this improves clinical outcomes is unknown. We aimed to determine whether the...
5.
Birch K, Burrows G, Cruickshank A, Egner W, Holbrook I, Lewis E, et al.
Ann Clin Biochem
. 2014 May;
51(Pt 6):657-61.
PMID: 24847134
Background: In cerebrospinal fluid (CSF) spectrophotometry, if the net bilirubin absorbance (NBA) and net oxyhaemoglobin absorbance (NOA) are both raised with a visible oxyhaemoglobin peak, the revised national guidelines for...
6.
Cruickshank A, Auld P, Beetham R, Burrows G, Egner W, Holbrook I, et al.
Ann Clin Biochem
. 2008 May;
45(Pt 3):238-44.
PMID: 18482910
It is crucially important to detect subarachnoid haemorrhage (SAH) in all patients in whom it has occurred to select patients for angiography and preventative surgery. A computerized tomography (CT) scan...
7.
Holbrook I, Beetham R, Cruickshank A, Egner W, Fahie-Wilson M, Keir G, et al.
Ann Clin Biochem
. 2007 Sep;
44(Pt 5):443-8.
PMID: 17761029
Background: UK National External Quality Assessment Service (NEQAS) Specialist Advisory Group for EQA of CSF Proteins and Biochemistry was interested in current practice for the biochemical investigation of cerebrospinal fluid...
8.
Holbrook I, Beetham R, Cruickshank A, Keir G, Watson I
Lancet
. 2007 Mar;
369(9565):904.
PMID: 17368148
No abstract available.
9.
Cruickshank A, Beetham R, Holbrook I, Watson I, Wenham P, Keir G, et al.
BMJ
. 2005 Jan;
330(7483):138.
PMID: 15649929
No abstract available.